Subscribe to our newsletter and stay informed

Check out our list of top companies

Check out our carefully compiled lists of the most relevant and impactful companies within their fields.

Check out our list of top unicorns

Read and learn about the biggest companies that various countries have produced, how they made it, and what the future looks like for them.
August 18, 2023

MIT-Dana-Farber Collaboration Taps Machine Learning to Decode Mysterious Tumors

OncoNPC's foresight empowers doctors to pinpoint ideal therapies for stubborn tumors

For a fraction of cancer patients, their tumors' origins remain a perplexing puzzle, stalling personalized treatments. A breakthrough by MIT and Dana-Farber Cancer Institute is rewriting the narrative. Harnessing machine learning, the researchers have crafted a groundbreaking computational model that dissects gene sequences to predict the source of enigmatic tumors.

This innovative approach successfully classified over 40% of tumors with unknown origins, offering a potential 2.2-fold surge in eligible patients for genomically guided treatments. The model's promise lies in its ability to assist doctors in prescribing tailored therapies, aligning with the trend toward personalized medicine.

“This model could be potentially used to aid treatment decisions, guiding doctors toward personalized treatments for patients with cancers of unknown primary origin,” explains Intae Moon, lead author, and MIT graduate student.

The implications extend beyond prediction, potentially impacting patient survival rates. An association was found between the model's prognosis and actual patient outcomes, reinforcing its validity. Even more intriguing, the model opened the door to expand the pool of patients eligible for existing precision treatments by 15%, without waiting for new drugs to be approved.

As the partnership between AI and medicine deepens, the researchers aspire to integrate additional data modalities like pathology and radiology images. This ambitious expansion could unlock more insights into tumor behavior, prognosis, and optimal treatment paths.

The journey towards unraveling the mysteries of cancer remains ongoing, with this collaboration proving that AI has a crucial role to play in understanding and conquering this complex disease.

This transformative research was funded from the National Institutes of Health, the Louis B. Mayer Foundation, the Doris Duke Charitable Foundation, the Phi Beta Psi Sorority, and the Emerson Collective.

Josefina Dipaolo
Josefina Dipaolo
Content Writer at TechNews180
Back to top

Related articles

chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram